AlphaYouAMPH: PETERS WILLIAM J discloses a sale
By AlphaYouPublished Form 4
PETERS WILLIAM J
Reporting filer
PETERS WILLIAM J reported Sale in Amphastar Pharmaceuticals, Inc.: 4139 units of Common Stock, dated 2026-09-21. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 23, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | PETERS WILLIAM J | 2026-09-21 | S | Sale | 4139 | 25 | 168,707 | 2 days | Filed terms
|
Common Stock
- Owner
- PETERS WILLIAM J
- Date
- 2026-09-21
- Code
- S
- Action
- Sale
- Quantity
- 4139
- Price
- 25
- Following holdings
- 168,707
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-21
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 4139
- transaction Price Per Share: 25
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 168707
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- PETERS WILLIAM J: CFO, EVP & TREASURER, Director.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.